Menu
SOPHiA GENETICSTM is excited to be a part of the European Society of Medical Oncology 2022 annual meeting, held in person and virtually in Paris, France from September 9-13.
You will have the chance to chat with our experts at booth #258 and schedule a demo universal SOPHiA DDM™ Platform.
Join us on September 10 from 17h-19h in Hall 5 Room 512 for a presentation on our CE-IVD certified SOPHiA DDMTM Dx Oncology Applications
What's New? CE-IVD Oncology Applications by SOPHiA GENETICS™
Alexander Kurze, PhD
Senior Director Product Management, SOPHiA GENETICS
Evaluation of a low-pass whole genome sequencing-based solution for homologous recombination deficiency detection supported by deep learning algorithms
Dr. Adrien Buisson
Praticien Spécialiste des CLCC – UF de Biologie des Tumeurs, Centre Léon Bérard- Cheney
Clinical validation of novel RNA fusion detection for NSCLC with SOPHiA DDMTM Dx RNAtarget Oncology Solution
Prof. Alexander Harlé, PhD
Biologist/Professor of liquid biopsy and tumor heterogeneity group, Institut de Cancérologie de Lorraine-Alexis Vautrin
Enabling clinical workflows in Trusted Research Environments
Gaetano Bonifacio, PhD
Industry Advisor-Healthcare, Microsoft
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
